2018 National and State Healthcare-Associated Infections (HAI) Progress Report

    November 2019

    The 2018 HAI Progress Report highlights significant progress in reducing some HAIs, while identifying areas where more improvements are needed. Between 2017 and 2018, significant national reductions in acute care hospitals (ACH) were seen in central line-associated bloodstream infections (CLABSI, 9%), catheter-associated urinary tract infections (CAUTI, 8%), and hospital-onset C. difficile infection (CDI, 12%), while no significant change was observed in hospital-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, ventilator-associated events (VAE), and surgical site infections (SSIs) related to 10 select procedures. In long-term acute care hospitals (LTACHs), significant reductions were seen in CAUTI (7%), hospital-onset CDI (18%), and hospital-onset MRSA bacteremia (21%) while no significant changes were observed in CLABSI (3%) and VAE (6%). In inpatient rehabilitation facilities (IRFs), a significant reduction was seen in hospital-onset CDI (20%) while no significant changes were seen in CLABSI, CAUTI, and MRSA bacteremia. The national progress in reducing HAIs shows that prevention is possible. Ongoing collaboration between public health, healthcare professionals, and other partners is critical to ensuring patient safety.


    • The number of hospitals that reported to NHSN and are included in the SIR calculation. This number may vary across HAI types; for example, some hospitals do not use central lines or urinary catheters, or do not perform colon or abdominal hysterectomy surgeries.